Latest stories

  • in

    Medical Bulletin 20/April/2023

    Here are the top medical news for the day: Risk or benefit of removing ovaries at benign hysterectomy Removal of the ovaries decreases the risk for ovarian cancer and greatly benefits the survival of women at high risk for ovarian cancer. However, not enough is known about how removal of the ovaries affects other possible […] More

  • in

    “Stuck” stem cells linked with hair graying: Study

    A new study shows certain stem cells to have a unique ability to move between growth compartments in hair follicles, but get stuck as people age and so lose their ability to mature and maintain hair color. Led by researchers from NYU Grossman School of Medicine, the new work focused on cells in the skin […] More

  • in

    Sugar-sweetened beverages may increase risk of premature death among people with type 2 diabetes

    Researchers at Harvard T.H. Chan School of Public Health have found in a new research that high consumption of sugar-sweetened beverages (SSBs) was associated with an elevated risk of premature death and incidence of cardiovascular disease (CVD) among people with type 2 diabetes.Therefore replacing sugary drinks with coffee, tea, or plain water is associated with […] More

  • in

    Resident T-cells crucial in salmonella immunity: Study

    When a pathogen enters the body, the immune system mounts a response, including CD4 T-cells which support other responses, such as antibody production by B-cells. When the infection is over, some of the cells specific to that pathogen remain as memory cells, waiting to be called rapidly into service again if the same threat returns. […] More

  • in

    Amubarvimab/romlusevimab reduces hospitalization and death by 79% in adults diagnosed with COVID-19: Study

    As COVID-19 evolves, the development of safe and effective therapeutics is a high priority. Amubarvimab and romlusevimab are non-competing anti-SARS-CoV-2 monoclonal antibodies with an extended half-life that may be an effective and safe option for persons who are at high risk of clinical progression to severe COVID-19. A randomized controlled trial of more than 800 […] More

  • in

    Abbott signals recovery in device sales as hospital staff shortages ease

    United States: Abbott Laboratories said on Wednesday most delayed non-urgent medical procedures had resumed globally three years into the COVID-19 pandemic as hospital staff shortages eased and customers became regular with check-ups, sending shares up 7%. The much-awaited recovery in elective surgeries led the company to effectively raise forecast for its core business, even as COVID […] More

  • in

    Risk or benefit of removing ovaries at benign hysterectomy

    Removal of the ovaries decreases the risk for ovarian cancer and greatly benefits the survival of women at high risk for ovarian cancer. However, not enough is known about how removal of the ovaries affects other possible outcomes, such as heart attack, stroke, other types of cancer, and how long patients live. An emulated target […] More

  • in

    3 more GMCs get NMC approval for 100 MBBS seats each, 6 new GMCs to begin classes this year in Telangana

    Hyderabad: The National Medical Commission (NMC) has recently approved 100 MBBS seats each at 3 more government medical colleges at Jangaon, Vikarabad, and Bhupalpally in Telangana. With this, NMC has accorded permission to 6 government medical colleges to start MBBS classes from the academic year 2023-24. Telangana Health Minister T Harish Rao in a tweet […] More

  • in

    Parkinson’s Disease: Does It Get Triggered By Head Trauma?

    Parkinson’s disease is the second most common degenerative brain disease after dementia. It is caused by a deficiency of an important chemical in the brain called dopamine, a lack of which causes slowness of an individual along with rigidity and tremors of hands and legs. For decades various medications have been used to alleviate the […] More

Load More
Congratulations. You've reached the end of the internet.